Literature DB >> 7692575

Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes.

M L Michel1, M Mancini, K Schlienger, P Tiollais.   

Abstract

Eukaryotic cells transformed with a plasmid expression vector are able to synthesize and assemble HBsAg, a complex multimeric lipoprotein particle. Hybrid particles carrying HIV1 antigenic determinants were constructed and injected into monkeys. A complete immune response including neutralizing antibodies, proliferative and cytotoxic T-cell activities was obtained. Thus, such HIV/HBsAg hybrid particles could be a new approach to multivalent vaccination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692575     DOI: 10.1016/s0923-2516(06)80038-5

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  3 in total

1.  In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.

Authors:  C Sedlik; G Dadaglio; M F Saron; E Deriaud; M Rojas; S I Casal; C Leclerc
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

Authors:  C Sedlik; M Saron; J Sarraseca; I Casal; C Leclerc
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Proposition of a three-dimensional representation of the constitutive protein of the hepatitis B surface antigen particles.

Authors:  N Sonveaux; J M Ruysschaert; R Brasseur
Journal:  J Protein Chem       Date:  1995-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.